For research use only
| Cat No. | ABC-X0324C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Lymphocytes |
| Species | Human |
| Host Cell | BAF3 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human HRAS (Q61L) BAF3 Cell Line facilitates studies on constitutive HRAS activation and its effects on oncogenic transformation and targeted therapy.
Human HRAS (Q61L) BAF3 Overexpression Cell Line is generated from Ba/F3 cells by lentiviral-mediated stable expression of human HRAS containing the Q61L mutation. The cells are maintained under low passage conditions (<P20) and validated via qRT-PCR. Target The Q61L mutation in HRAS results in defective GTPase activity and persistent activation of the MAPK pathway, contributing to tumor initiation and progression. This alteration is frequently found in bladder, thyroid, and skin cancers. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers' research needs.
| Species | Human |
| Cat.No | ABC-X0324C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphocytes |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | BAF3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
This cell model is widely used to investigate HRAS Q61L-induced oncogenesis and to develop therapeutics targeting the RAS signaling axis in HRAS-driven malignancies.